Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Stage

Series B | Alive

Total Raised

$10.74M

Last Raised

$10M | 8 yrs ago

About MYR

MYR is a German biotechnology company developing Myrcludex B, a drug for the treatment of chronic hepatitis B and delta virus infections. The drug inhibits the recently identified HBV receptor on the hepatocyte surface and prevents the infection of the healthy cells and viral spreading within the liver.

MYR Headquarters Location

Eiermarkt 3 c

Burgwedel, D-30938,

Germany

49 5139 894379

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

MYR Patents

MYR has filed 4 patents.

The 3 most popular patent topics include:

  • Autoimmune diseases
  • Hepatology
  • Animal viral diseases
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/12/2018

2/23/2021

Transcription factors, Hepatology, Rare diseases, Autoimmune diseases, Clusters of differentiation

Grant

Application Date

4/12/2018

Grant Date

2/23/2021

Title

Related Topics

Transcription factors, Hepatology, Rare diseases, Autoimmune diseases, Clusters of differentiation

Status

Grant

  • Where is MYR's headquarters?

    MYR's headquarters is located at Eiermarkt 3 c, Burgwedel.

  • What is MYR's latest funding round?

    MYR's latest funding round is Series B.

  • How much did MYR raise?

    MYR raised a total of $10.74M.

  • Who are the investors of MYR?

    Investors of MYR include High-Tech Grunderfonds and Maxwell Biotech Venture Fund.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.